Cloning of Streptococcus pyogenes streptokinase gene in E.coli
elham siasi-torbati
1
(
Faculty of Biological Sciences, Tehran-North Branch, Islamic Azad University, Tehran, Iran
)
fatemeh fakhrefatemi
2
(
Department of Biotechnology, Collage of science, North Tehran Branch, Islamic Azad University, Tehran, Iran
)
میترا صاحی
3
(
)
Keywords: Cloning, E.coli XL1Blue, ska gene, Streptococcus pyogenes, Streptokinase.,
Abstract :
Aim and Background: Streptokinase is a thrombolytic medication and enzyme and is used to break down clots in some cases of myocardial infarction (heart attack), pulmonary embolism, and arterial thromboembolism. Recently recombinant streptokinase is important for treatment. In this research, was studied cloning of Streptococcus pyogenes streptokinase gene in E.coli. Materials and methods: At the first, genome of the bacteria was extracted and used PCR for ska gene. Then agarose gel electrophoresis was performed for detection of size and quality of the resulting amplicons. Then by TA Cloning kit, the target gene was inserted in to the PTG19 Cloning vector and the recombinant plasmid was inserted in to the E.coli XL1Blue bacteria. Checking the sequencing data obtained from cloned gene in the vectore compared with the refrenece sequenece obtained from the NCBI database, was confirmed the success of the gene cloning. Results: The results showed that PCR product is ska gene with length 513 bp. This is for the first time that the ska gene was cloned by the TA Cloning in the PTG19 vector and the E.coli XL1Blue host cell. The results of sequencing was confirmed presence of Streptokinase gene, ska. Conclusion: The ska gene was amplified and its correct and effective cloning was confirmed by TA Cloning with PTG19 vector and E.coli XL1Blue host cell.
1- Nagamalesh UM, Prakash VS, Naidu KCK, Sarthak S, Hegde AV, Abhinay T. Acut pulmonary
thromboembolism: Epidemiology, predictors, and long-term outcome - A single center experience. Indiana
Heart J. 2017; 69(2): 160-164.
2. Monzavi N, Aghasadeghi MR, Arabi R, Memarnejadian A, Sadat M, Khanahmad H, Ebrahimi M,
Roohhvand F. Design, cloning, expression and evaluation of cysteine- substitutes of intact and truncated
molecules of streptokinase. Physiology and Pharmacology. 2010; 14 (1): 56 – 65.
3. Banerjee A, Chisti Y, Banerjee U. Streptokinase--a clinically useful thrombolytic agent. Biotechnol Advance. 2004; 22(4): 287–307.
4. Parker W, Storey R. Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54. Heart. 2016; 102(10): 783–789.
5. Maheshwari N, Kantipudi S, Maheshwari A, Arora K, Vandana, Kwatra N, Sahni G. Amino-Terminal Fusion of Epidermal Growth Factor 4,5,6 Domains of Human Thrombomodulin on Streptokinase Confers Anti-Reocclusion Characteristics along with Plasmin-Mediated Clot Specificity. PLoS One. 2016; 11(3): e0150315.
6. Vellanki R, Potumarthi R, Doddapaneni K, Anubrolu N, Mangamoori L. Constitutive optimized production of streptokinase in Saccharomyces cerevisiae utilizing glyceraldehyde 3-phosphate dehydrogenase promoter of Pichia pastoris. Biomed Res Int. 2013; 20(13): 268-249.
7. Jafari R, Mirshahi M. Production and purification of recombinant streptokinase Using pMAL expression
vector. Tehran University Medical Journal. 2007; 65(1): 13-18.
8. Lotfi A, Schweiger MJ, Giugliano G, Murphy S, Cannon CP. High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients-a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis. Am Heart J. 2008; 155(5): 954–958.
9. Brown T. Gene cloning and DNA analysis. John Wiley & Sons Ltd press, UK. 6 th edition. 2010: 328-338.
10. Doogab Y. Genetic Engineering and its Emergence in Biotechnology. University of Chicago Press, USA. 1th edition. 2015: 103-260.
11. Kunamneni A, Abdelghani T, Ellaiah P. Streptokinase--the drug of choice for thrombolytic therapy. Journal Thromb Thrombolysis. 2007; 23(1): 9–23.
12. Kumar R, Singh J. Expression and secretion of a prokaryotic protein streptokinase without glycosylation and degradation in Schizosaccharomyces pombe. Yeast. 2004; 21(16): 1343–1358.
13. Adivitiya-Dagar V, Devi N, Khasa Y. High level production of active streptokinase in Pichia pastoris fed-batch culture. Int J Biol Macromol. 2016; 83: 50–60.
14. Malke H, Steiner K, Gase K, Frank C. Expression and regulation of the streptokinase gene. Methods. 2000; 21(2): 111–124.
15. Pratap J, Rajamohan G, Dikshit K. Characteristics of glycosylated streptokinase secreted from Pichia pastoris: enhanced resistance of SK to proteolysis by glycosylation. Appl Microbiol Biotechnol. 2000; 53(4): 469–475.
16. Tharp AC, Laha M, Panizzi P, Thompson MW, Fuentes-Prior P, Bock P. Plasminogen substrate recognition by the streptokinase-plasminogen catalytic complex is facilitated by Arg253, Lys256, and Lys257 in the streptokinase beta-domain and kringle 5 of the substrate. J Biol Chem. 2009; 284(29): 19511–1921.
17. Yadav S, Aneja R, Kumar P, Datt M, Sinha S, Sahni G. Identification through combinatorial random and rational mutagenesis of a substrate-interacting exosite in the gamma domain of streptokinase. J Biol Chem. 2011; 286(8): 6458–6469.
18. Molaee N, Abtahi H, Mosayebi Gh. Expression of Recombinant Streptokinase from Streptococcus
Pyogenes and its Reaction with Infected Human and Murine Sera. Iran J Basic Med Sci. 2013; 16(9): 985-
989.
19. Arabi R, Roohvand F, Noruzian, Aghasadeghi MR, Memarnejadian A, Khanahmad H, Sadat M, Motevali
F. Cloning and expression of truncated and intact streptokinase molecules in E.coli and evaluation of their
biological activities. Journal Agriculture Biotechnology. 2011; 2(1): 55-67.
20. Njadmoghadam MR, Modaresi M, Babashamsi M, Chamankhah M. Streptokinase: extraction, cloning and
high expression of active recombinant protine with facility in purification. Journal of shahid beheshti medical
science University. 2006; 30(3): 245-252.
21. Bagheri S, Maghsoudi H, Motevalli F, KhoshdelNezamiha F, Hasanzadeh SM, Arabi-Mianroodi R. Site-
Directed Mutation,Cloning and Expression of Streptokinase for reducing a New Suitable Molecule for
PEGylation. Arak Medical University Journal. 2016; 19(108): 1-10.
